| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Yun-Long Chen, Xiao-Qi Huang, Shi-Jie Xu, Jin-Bin Liao, Ru-Jun Wang, Xiao-Feng Lu, You-Liang Xie, Fu-Sheng Zhou, Zi-Ren Su, Xiao-Ping La. Relieving visceral hyperalgesia effect of Kangtai capsule and its potential mechanisms via modulating the 5-HT and NO level in vivo. Phytomedicine : international journal of phytotherapy and phytopharmacology. vol 20. issue 3-4. 2013-07-30. PMID:23141427. |
furthermore, kt at three doses significantly decreased 5-ht content from distal colon of visceral hyperalgesia rats induced by nms, while the significant decrease of 5-ht content in serum was only observed in the group with kt at high dose. |
2013-07-30 |
2023-08-12 |
rat |
| Yun-Long Chen, Xiao-Qi Huang, Shi-Jie Xu, Jin-Bin Liao, Ru-Jun Wang, Xiao-Feng Lu, You-Liang Xie, Fu-Sheng Zhou, Zi-Ren Su, Xiao-Ping La. Relieving visceral hyperalgesia effect of Kangtai capsule and its potential mechanisms via modulating the 5-HT and NO level in vivo. Phytomedicine : international journal of phytotherapy and phytopharmacology. vol 20. issue 3-4. 2013-07-30. PMID:23141427. |
however, compared with that in nms rats without kt, there was no apparent difference of 5-ht level from brain issue in the rats with various doses. |
2013-07-30 |
2023-08-12 |
rat |
| Paul J Perry, Courtney A Wilbor. Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 24. issue 2. 2012-09-06. PMID:22563571. |
serotonin syndrome (ss) and neuroleptic malignant syndrome (nms) are uncommon but potentially life-threatening adverse reactions associated with psychotropic medications. |
2012-09-06 |
2023-08-12 |
Not clear |
| Zhao-Xiang Bian, Hong-Yan Qin, Shun-Lian Tian, Sheng-Da Q. Combined effect of early life stress and acute stress on colonic sensory and motor responses through serotonin pathways: differences between proximal and distal colon in rats. Stress (Amsterdam, Netherlands). vol 14. issue 4. 2011-10-07. PMID:21438781. |
consecutive administration of parachlorophenylalanine to nms rats was more potent at 500 mg kg⁻¹ day⁻¹ than at 150 mg kg⁻¹ day⁻¹ in suppressing colonic sensory/motor responses to was, corresponding to the greater reduction of the tissue and faecal content of 5-ht and of ec cell density in the colon. |
2011-10-07 |
2023-08-12 |
rat |
| Michele Fornar. Catatonia: a narrative review. Central nervous system agents in medicinal chemistry. vol 11. issue 1. 2011-06-17. PMID:21294706. |
what is clear is that neurotransmitters, such as dopamine (da), gamma-aminobutyric acid (gaba), and glutamate (glu), are of major importance in the pathogenesis of catatonia and neuroleptic malignant syndrome (nms) and that serotonin (5-hydroxytryptamine [5-ht]) is crucial to the development of serotonin syndrome (ss). |
2011-06-17 |
2023-08-12 |
Not clear |
| P Ken Gillma. Neuroleptic malignant syndrome: mechanisms, interactions, and causality. Movement disorders : official journal of the Movement Disorder Society. vol 25. issue 12. 2010-12-28. PMID:20623765. |
the formal criteria for substantiating cause-effect relationships in medical science, established by hill, are applied to nms and, for comparison, also to malignant hyperthermia and serotonin toxicity. |
2010-12-28 |
2023-08-12 |
human |
| Yuji Odagak. Atypical neuroleptic malignant syndrome or serotonin toxicity associated with atypical antipsychotics? Current drug safety. vol 4. issue 1. 2009-03-31. PMID:19149529. |
in the present review, the author addressed himself to the issues surrounding the neurotoxic reaction to the treatment regimen containing atypical antipsychotics, focusing on the "atypical" forms of nms and pathophysiological as well as clinical features of serotonin toxicity. |
2009-03-31 |
2023-08-12 |
Not clear |
| Yuji Odagak. Atypical neuroleptic malignant syndrome or serotonin toxicity associated with atypical antipsychotics? Current drug safety. vol 4. issue 1. 2009-03-31. PMID:19149529. |
the reciprocal interaction between the dopaminergic and serotonergic systems disturbed by either dopaminergic blockers or serotonergic enhancers leads to the disruption of homeostasis, with typical forms of nms and serotonin syndrome representing the ends of the common pathophysiological background. |
2009-03-31 |
2023-08-12 |
Not clear |
| Koichi Nisijima, Katsutoshi Shioda, Tatsunori Iwamur. Neuroleptic malignant syndrome and serotonin syndrome. Progress in brain research. vol 162. 2008-04-07. PMID:17645916. |
neuroleptic malignant syndrome (nms) develops during the use of neuroleptics, whereas serotonin syndrome is caused mainly by serotoninergic antidepressants. |
2008-04-07 |
2023-08-12 |
Not clear |
| Brendan T Carroll, Joseph W Y Lee, Kevin T Graham, Arthur Thalassinos, Christopher Thomas, Rob Kirkhar. Diagnosing subtypes of neuroleptic malignant syndrome: an introduction to the Lee-Carroll Scale. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 20. issue 1. 2008-04-07. PMID:18297586. |
neuroleptic malignant syndrome (nms) shares common features with catatonia and serotonin syndrome (ss). |
2008-04-07 |
2023-08-12 |
Not clear |
| Kenneth R Kaufman, Michael J Levitt, John F Schiltz, Jagadeeshan Sunderra. Neuroleptic malignant syndrome and serotonin syndrome in the critical care setting: case analysis. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 18. issue 3. 2007-01-18. PMID:16923659. |
serotonin syndrome (ss) and neuroleptic malignant syndrome (nms) are medical emergencies associated with psychotropic administration. |
2007-01-18 |
2023-08-12 |
Not clear |
| Jason Vena, Susan Dufel, Todd Paig. Acute olanzapine-induced akathisia and dystonia in a patient discontinued from fluoxetine. The Journal of emergency medicine. vol 30. issue 3. 2006-10-12. PMID:16677985. |
the possibility of neuroleptic malignant syndrome (nms), serotonin syndrome (ss), tricyclic overdose, and cocaine abuse should be considered in a patient with extrapyramidal signs and symptoms, given the potential for complications. |
2006-10-12 |
2023-08-12 |
Not clear |
| Ahmet Tiryaki, Gökhan Kandemir, Ismail A. [The life threatening adverse effects of psychotropic drugs: a case report]. Turk psikiyatri dergisi = Turkish journal of psychiatry. vol 17. issue 2. 2006-06-27. PMID:16755415. |
signs and symptoms of serotonin syndrome (ss) can be grouped into four inclusive categories that are almost identical to those of nms. |
2006-06-27 |
2023-08-12 |
Not clear |
| Ahmet Tiryaki, Gökhan Kandemir, Ismail A. [The life threatening adverse effects of psychotropic drugs: a case report]. Turk psikiyatri dergisi = Turkish journal of psychiatry. vol 17. issue 2. 2006-06-27. PMID:16755415. |
we present a case of a 42-year-old male with a history of schizophrenia that developed signs and symptoms inconsistent with either nms or ss after intramuscular administration of 2 typical antipsychotics along with 1 dose of a selective serotonin reuptake inhibitor (ssri). |
2006-06-27 |
2023-08-12 |
Not clear |
| Tsung-Chien Lu, Pei-Lun Chu, Chi-Shin Wu, Kuang-Chau Tsai, Wen-Jone Che. Neuroleptic malignant syndrome after the use of venlafaxine in a patient with generalized anxiety disorder. Journal of the Formosan Medical Association = Taiwan yi zhi. vol 105. issue 1. 2006-02-28. PMID:16440077. |
nms was considered to have been caused by the recent addition and subsequent dose increase in his treatment regimen of venlafaxine, a serotonin norepinephrine reuptake inhibitor. |
2006-02-28 |
2023-08-12 |
Not clear |
| Daniel E Rusyniak, Jon E Spragu. Toxin-induced hyperthermic syndromes. The Medical clinics of North America. vol 89. issue 6. 2005-12-22. PMID:16227063. |
in those patients in whom it is difficult to differentiate between serotonin and neuroleptic malignant syndromes, the physical examination may be helpful:clonus and hyperreflexia are more suggestive of serotonin syndrome,whereas lead-pipe rigidity is suggestive of nms. |
2005-12-22 |
2023-08-12 |
Not clear |
| Daniel E Rusyniak, Jon E Spragu. Toxin-induced hyperthermic syndromes. The Medical clinics of North America. vol 89. issue 6. 2005-12-22. PMID:16227063. |
in patients in whom serotonin syndrome and nms cannot be differentiated, benzodiazepines represent the safest therapeutic option. |
2005-12-22 |
2023-08-12 |
Not clear |
| B Spivak, D I Maline, Y Vered, V N Kozyrev, R Mester, S A Neduva, R S Ravilov, E Graff, A Weizma. Prospective evaluation of circulatory levels of catecholamines and serotonin in neuroleptic malignant syndrome. Acta psychiatrica Scandinavica. vol 102. issue 3. 2001-02-02. PMID:11008859. |
the objective of the present study was to evaluate prospectively the circulatory levels of serotonin (5-ht), epinephrine (e) and dopa in patients suffering from nms. |
2001-02-02 |
2023-08-12 |
Not clear |
| A Takahashi, J Todoroki, M Murasak. [Neuroleptic malignant syndrome, syndrome malin]. Nihon rinsho. Japanese journal of clinical medicine. vol 54. issue 3. 1997-02-28. PMID:8904246. |
in addition, it is thought that several neurotransmitters, serotonin, noradrenaline and gaba, are related in the mechanism of nms. |
1997-02-28 |
2023-08-12 |
Not clear |
| M G von Halling Laier, L F Gra. [Serotonin syndrome and malignant neuroleptic syndrome. A review based on the material from the National Board of Adverse Drug Reactions]. Ugeskrift for laeger. vol 158. issue 48. 1997-01-07. PMID:8984761. |
the report describes four cases of serotonergic hyperstimulation classified as serotonin syndrome (ss) and 13 cases of supposed neuroleptic malignant syndrome (nms), all reported to the national board of adverse drug reactions. |
1997-01-07 |
2023-08-12 |
Not clear |